Marker, lesion localization, implantable
ARTG ID: 481126 · Medtronic Australasia Pty Ltd · Covidien llc · Class IIb · Started February 27, 2025
Good Name: Medtronic Australasia Pty Ltd - Marker, lesion localization, implantable
- Risk Class
- Class IIb
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 481126
- Start Date
- February 27, 2025
- Effective Date
- February 27, 2025
- Name
- Covidien llc
- Country
- United States of America
- Address
- 15 Hampshire Street, Mansfield, MA, 02048
The device is intended to implant fiducial markers under endoscopic ultrasound to radiographically mark soft tissue for future therapeutic procedures.
Access comprehensive regulatory information for Marker, lesion localization, implantable in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 481126 and sponsored by Medtronic Australasia Pty Ltd, manufactured by Covidien llc in United States of America. The device registration started on February 27, 2025.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.